hat
Testostewòn gen efè negatif negatif sou sistèm nan kadyovaskilè, pi miyò sou chanjman nan negatif nan kolestewòl Des. Testostewòn itilize pou kont li fè pwomosyon yon rediksyon modere nan HDL ('bon' kolestewòl) [7], men syans yo te demontre menm vin pi mal chanjman lè li konbine avèk itilizasyon inhibiteur aromatase, sa ki lakòz yon ogmantasyon anplis nan LDL (kolestewòl move ' ) e menm pi gwo nan HDL [8].
eng
Testosterone has demonstrable negative effects on the cardiovascular system, most notably on the negative alteration of cholesterol profiles. Testosterone use alone promotes a low to moderate reduction of HDL (‘good’ cholesterol)[7], but studies have demonstrated even worse alterations when it is combined with the use of aromatase inhibitors, causing an additional increase in LDL (‘bad’ cholesterol) and even larger decreases in HDL[8].